Expertise in
3
conditions

Michael Cardamone

High Street, 
Randwick, NSW, AU 
Expertise in
3
conditions
High Street, 
Randwick, NSW, AU 

Overview

Michael Cardamone practices practicing medicine in Randwick, Australia.

Mr. Cardamone is highly rated in 3 conditions, according to our data. His clinical expertise encompasses West Syndrome, Micrognathia, Epilepsy in Children, and Epilepsy.

He is actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

High Street, Randwick, NSW 2031, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
Enrollment Status: Completed
Publish Date: September 04, 2026
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
View 1 Less Clinical Trial

36 Total Publications

Eligibility for Thrombolysis for Pediatric Acute Ischemic Stroke.
Eligibility for Thrombolysis for Pediatric Acute Ischemic Stroke.
Journal: Stroke
Published: August 27, 2026

Frequently Asked Questions about Michael Cardamone

Is Michael Cardamone a top-rated expert for West Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Michael Cardamone is classified as an Advanced expert for West Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michael Cardamone participate in research or clinical trials?

Yes. Michael Cardamone has published 36 articles and abstracts on conditions like West Syndrome. You can view a list of Michael Cardamone's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cardamone's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile